Prescribing Appropriate Medicines to Older Adults: A Finnish Experience with the Web-Based Meds75+ Database.

IF 3.4 3区 医学 Q2 GERIATRICS & GERONTOLOGY
Drugs & Aging Pub Date : 2024-08-01 Epub Date: 2024-07-31 DOI:10.1007/s40266-024-01131-y
Johanna Jyrkkä, Jasmin Paulamäki, Sirpa Hartikainen, Jouni Ahonen, Riitta Antikainen, Hanna-Mari Jauhonen, Esa Jämsen, Anniina Kössi, Jouko Laurila, Hanna-Maria Roitto, Riikka Söderling, Miia Tiihonen, Risto Huupponen
{"title":"Prescribing Appropriate Medicines to Older Adults: A Finnish Experience with the Web-Based Meds75+ Database.","authors":"Johanna Jyrkkä, Jasmin Paulamäki, Sirpa Hartikainen, Jouni Ahonen, Riitta Antikainen, Hanna-Mari Jauhonen, Esa Jämsen, Anniina Kössi, Jouko Laurila, Hanna-Maria Roitto, Riikka Söderling, Miia Tiihonen, Risto Huupponen","doi":"10.1007/s40266-024-01131-y","DOIUrl":null,"url":null,"abstract":"<p><p>The Finnish web-based Meds75+ database supports rational, safe and appropriate prescribing to older adults in primary care. This article describes the content and updating process of Meds75+ and demonstrates its applicability in everyday clinical practice. Meds75+ contains a classification (A-D) and recommendation texts for 450-500 drug substances when used in the treatment of older adults aged 75 years or older. The content of Meds75+ is continually updated. Each assessment of a drug substance begins with a structured collection of available information and research evidence. After that, an interdisciplinary expert panel discusses the classification and recommendation using a consensus method. A rolling 3-year updating cycle guarantees that all drug substances are reviewed regularly. Most drug substances are classified as class A (41%) (suitable, e.g. bisoprolol) or as class C (37%) (suitable with specific precautions, e.g. ibuprofen). One-fifth (20%) of the substances are in class D (avoid use, e.g. diazepam). Most commonly, older adults have purchased substances affecting the alimentary tract and metabolism (17%), the nervous system (16%) and the cardiovascular system (15%). In Finland, the proportion of older adults using class D substances (37%) has not changed between the years 2019 and 2022. Meds75+ has potential to support safer and more effective use of medications for older adults, since it offers up-to-date information on drug substances for healthcare professionals.</p>","PeriodicalId":11489,"journal":{"name":"Drugs & Aging","volume":" ","pages":"665-674"},"PeriodicalIF":3.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11322211/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs & Aging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40266-024-01131-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The Finnish web-based Meds75+ database supports rational, safe and appropriate prescribing to older adults in primary care. This article describes the content and updating process of Meds75+ and demonstrates its applicability in everyday clinical practice. Meds75+ contains a classification (A-D) and recommendation texts for 450-500 drug substances when used in the treatment of older adults aged 75 years or older. The content of Meds75+ is continually updated. Each assessment of a drug substance begins with a structured collection of available information and research evidence. After that, an interdisciplinary expert panel discusses the classification and recommendation using a consensus method. A rolling 3-year updating cycle guarantees that all drug substances are reviewed regularly. Most drug substances are classified as class A (41%) (suitable, e.g. bisoprolol) or as class C (37%) (suitable with specific precautions, e.g. ibuprofen). One-fifth (20%) of the substances are in class D (avoid use, e.g. diazepam). Most commonly, older adults have purchased substances affecting the alimentary tract and metabolism (17%), the nervous system (16%) and the cardiovascular system (15%). In Finland, the proportion of older adults using class D substances (37%) has not changed between the years 2019 and 2022. Meds75+ has potential to support safer and more effective use of medications for older adults, since it offers up-to-date information on drug substances for healthcare professionals.

Abstract Image

为老年人开具适当的药物处方:芬兰使用基于网络的 Meds75+ 数据库的经验。
芬兰基于网络的 Meds75+ 数据库支持在初级保健中为老年人开具合理、安全和适当的处方。本文介绍了 Meds75+ 的内容和更新过程,并展示了其在日常临床实践中的适用性。Meds75+ 包含用于治疗 75 岁或以上老年人的 450-500 种药物的分类(A-D)和推荐文本。Meds75+ 的内容不断更新。每次评估一种药物时,首先要有条理地收集现有信息和研究证据。然后,跨学科专家小组采用协商一致的方法讨论分类和建议。3 年滚动更新周期保证了所有药物物质都能得到定期审查。大多数药物物质被划分为 A 类(41%)(适用,如比索洛尔)或 C 类(37%)(适用并有特定的预防措施,如布洛芬)。五分之一(20%)的药物属于 D 类(避免使用,如地西泮)。最常见的是,老年人购买了影响消化道和新陈代谢(17%)、神经系统(16%)和心血管系统(15%)的物质。在芬兰,使用 D 类药物的老年人比例(37%)在 2019 年和 2022 年之间没有变化。Meds75+ 为医疗保健专业人员提供了最新的药物信息,因此有可能帮助老年人更安全、更有效地使用药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drugs & Aging
Drugs & Aging 医学-老年医学
CiteScore
5.50
自引率
7.10%
发文量
68
审稿时长
6-12 weeks
期刊介绍: Drugs & Aging delivers essential information on the most important aspects of drug therapy to professionals involved in the care of the elderly. The journal addresses in a timely way the major issues relating to drug therapy in older adults including: the management of specific diseases, particularly those associated with aging, age-related physiological changes impacting drug therapy, drug utilization and prescribing in the elderly, polypharmacy and drug interactions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信